Regarding TXA administration, the guidelines listed in the Companion document outline administration methods (in a 50cc bag or in a 10cc syringe IV over 5 minutes to avoid exacerbating hypotension). However, some services practice administering TXA in a 500 cc bag and infusing a bolus, as advised by their service. Is this an additional administrative option that is being considered for services by Base Hospital for hemorrhagic events, or is this service-dependent?
Also, a rare but plausible question— in the Companion document, it outlines "recommended" IM injection sites. Considering risk versus reward, and assuming a patient has bilateral femur fractures, can TXA be administered in the buttocks (5 mL and 5 mL bilaterally)? It may seem like a silly question, since my interpretation of "recommended" may differ from others. Some services are stern and state the only "approved" IM injection sites are the vastus lateralis: 5 mL, and the deltoid: 2.5 mL, indicating that paramedics are not allowed to utilize other IM injection sites. Personally, I consider the term "recommended" as the preferred method, but not the only method. Again, the risk of injections in the buttock is a high risk of adverse effects; however, if it was documented, the reasoning behind it, whether it's access or injury, would this be appropriate without the need to contact the base hospital over an injection site?